Conclusions regarding relative cost-utility of alternative strategies for use of aromatase inhibitors in postmenopausal women with early breast cancer are premature.

Delea, T E

Conclusions regarding relative cost-utility of alternative strategies for use of aromatase inhibitors in postmenopausal women with early breast cancer are premature. [electronic resource] - Annals of oncology : official journal of the European Society for Medical Oncology Jan 2007 - 197-198 p. digital

Publication Type: Comment; Letter

0923-7534

10.1093/annonc/mdl171 doi


Aromatase Inhibitors--economics
Breast Neoplasms--drug therapy
Cost-Benefit Analysis
Drug Costs
Female
Humans
Postmenopause